rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6052
|
pubmed:dateCreated |
1977-3-15
|
pubmed:abstractText |
A trial of low-dose subcutaneous heparin to prevent thromboembolic complications after myocardial infarction was carried out in 78 patients. Of the 37 heparin-treated patients only two (5%) developed evidence of leg vein thrombosis, while 14 (34%) of the 41 controls did so, and five controls developed pulmonary emboli. Leg vein thrombosis developed in 12 (50%) of the 24 controls who did not smoke cigarettes but in only two (13%) of the 17 controls who were cigarette smokers. Non-smokers who have a myocardial infarction should be given low-dose heparin subcutaneously to prevent leg vein thrombosis and pulmonary embolism.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0007-1447
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18-20
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:831965-Aged,
pubmed-meshheading:831965-Female,
pubmed-meshheading:831965-Heparin,
pubmed-meshheading:831965-Humans,
pubmed-meshheading:831965-Male,
pubmed-meshheading:831965-Middle Aged,
pubmed-meshheading:831965-Myocardial Infarction,
pubmed-meshheading:831965-Pulmonary Embolism,
pubmed-meshheading:831965-Smoking,
pubmed-meshheading:831965-Thromboembolism,
pubmed-meshheading:831965-Thrombophlebitis
|
pubmed:year |
1977
|
pubmed:articleTitle |
Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|